If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Director/PDMR Shareholding

8 Mar 2022 09:41

RNS Number : 0120E
Braveheart Investment Group plc
08 March 2022
ย 

8 March 2022

Braveheart Investment Group plc

("Braveheart" or the "Group")

ย 

Director/PDMR Shareholding

ย 

Notification of Transactions of Persons Discharging Managerial Responsibilities (PDMRs)

Braveheart was notified on 7 March 2022 that Trevor Brown of Braveheart, a person discharging managerial responsibilities ("PDMR") of the Company, has purchased 100,000 Ordinary Shares of 2 pence each in the Group ("Ordinary Shares") at an average price of ยฃ0.115 per share. Trevor Brown now holds a total beneficial interest in 3,976,013 Ordinary Shares (equivalent to 7.61 per cent. of the Company's voting rights).

Details of the transaction can be found in the Notification of Dealing Form below.

ย 

1

ย 

Details of the person discharging managerial responsibilities / person closely associated

ย 

a)

ย 

Name

ย 

Trevor Brown

ย 

2

ย 

Reason for the notification

ย 

a)

ย 

Position/status

ย 

Director

ย 

b)

ย 

Initial notification /Amendment

ย 

Initial Notification

3

ย 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

ย 

a)

ย 

Name

ย 

Braveheart Investment Group plc

b)

ย 

LEI

ย 

2138006HQ3COMU626I61

4

ย 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

ย 

a)

ย 

Description of the financial instrument, type of instrument

ย 

Identification code

ย 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

ย 

GB00B13XV322

b)

ย 

Nature of the transactions

ย 

Purchase of ordinary shares

c)

ย 

Price(s) and volume(s)

ย 

ย 

Price(s)

ย 

11.5p

ย 

Volume(s)

ย 

100,000

ย 

d)

ย 

Aggregated information

- Aggregated volume

- Price

- Principal amount

ย 

ย 

100,000

11.5p

ยฃ11,500

e)

ย 

Dates of the transaction

ย 

7 March 2022

f)

Place of transaction

London Stock Exchange, AIM Market

ย 

For further information:

ย 

Braveheart Investment Group plcTrevor Brown, Chief Executive Officer

ย 

ย 

Tel: 01738 587555

Allenby Capital Limited (Nominated Adviser and Joint Broker) David Worlidge / George Payne

ย 

Tel: 020 3328 5656

ย 

ย 

Peterhouse Capital Limited (Joint Broker) Heena Karani / Lucy Williams

ย 

ย 

Tel: 020 7469 0936

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
DSHGCGDXCXGDGDI
Date   Source Headline
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:00 pmRNSPrice Monitoring Extension
23rd Oct 20207:00 amRNSUpdate on Pharm2Farm’s COVID-19 mask project
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202012:42 pmRNSFurther re. Conditional Sale of Pharm2Farm holding
19th Oct 202012:35 pmRNSPublication of Circular and Notice of GM
16th Oct 20207:00 amRNSFurther update re Paraytec Limited
8th Oct 20204:09 pmRNSUpdate on Pharm2Farm
5th Oct 202011:20 amRNSFurther update re Paraytec Limited
29th Sep 20204:40 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
24th Sep 20207:00 amRNSUpdate on Phasefocus Holdings Limited
18th Sep 20207:00 amRNSUpdate on the Pharm2Farm anti-viral mask project
8th Sep 202012:18 pmRNSResult of AGM
3rd Sep 20207:00 amRNSFurther re Paraytec Limited
28th Aug 20205:00 pmRNSTotal Voting Rights
21st Aug 20205:09 pmRNSConditional Sale of Pharm 2 Farm Limited holding
20th Aug 20201:04 pmRNSHolding(s) in Company
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20207:00 amRNSFurther re Paraytec Limited
4th Aug 20207:00 amRNSFinal Results
23rd Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20207:18 amRNSParticipation in RMS placing
7th Jul 20207:00 amRNSFurther re Paraytec Limited
1st Jul 20202:31 pmRNSHolding(s) in Company
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20203:00 pmRNSAcquisition of 18.1% interest in RMS
19th Jun 20202:29 pmRNSOperational Update
9th Jun 20207:00 amRNSFurther re Paraytec Limited
8th Jun 20207:00 amRNSHolding(s) in Company
5th Jun 202012:44 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSAcquisition of Additional PhaseFocus Shares
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:36 pmRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSOperational update on Kirkstall Limited
1st Jun 20207:00 amRNSFurther re Paraytec Limited
29th May 20205:00 pmRNSTotal Voting Rights
21st May 20207:00 amRNSHolding in Phasefocus increased and other matters
20th May 20202:05 pmRNSSecond Price Monitoring Extn
20th May 20202:00 pmRNSPrice Monitoring Extension
20th May 202011:05 amRNSSecond Price Monitoring Extn
20th May 202011:00 amRNSPrice Monitoring Extension
20th May 20209:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.